About the Prenatal Screening Session
Prenatal care procedures that concentrate on identifying issues with the pregnancy as early as feasible include prenatal screening and prenatal diagnosis, which are both parts of prenatal testing. These may be physiologic and anatomical issues with the zygote, embryo, or fetus's health, either before gestation even begins or as early as is practical. Genetic disorders and birth defects like spina bifida, cleft palate, Down syndrome, Tay-Sachs disease, sickle cell anemia, thalassemia, cystic fibrosis, muscular dystrophy, and fragile X syndrome can be identified through screening for issues like neural tube defects, chromosome abnormalities, and gene mutations. Some tests, like the PAPP-A test for pre-eclampsia or glucose tolerance tests, are intended to find issues that primarily affect the mother's health.
Topics Covered in Prenatal Screening
First and second trimester screening tests
Non-invasive prenatal testing and cell-free DNA
Chromosomal abnormality and aneuploidy detection
Neural tube and structural birth defect screening
Carrier screening for inherited disorders
Counselling, consent and ethics in prenatal testing
Featured Speakers — Prenatal Screening 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Prenatal Screening Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IPHC 2027
Why Attend the Prenatal Screening Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Prenatal Screening work, reviewed by the scientific committee.
Network Globally
Meet public health researchers, educators, and policy leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Prenatal Screening research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IPHC 2027 for the Prenatal Screening track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Prenatal Screening Conference 2027 — FAQs
What is the Prenatal Screening track at IPHC 2027?
The Prenatal Screening track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Prenatal Screening. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Prenatal Screening sessions?
Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Prenatal Screening are all welcome — whether presenting or attending.
Can I present my research in the Prenatal Screening track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Prenatal Screening sessions?
Yes. IPHC 2027 is a hybrid conference — attend the Prenatal Screening track in person in Singapore or join live online, with on-demand access afterward.
Join the IPHC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.